Abstract
Rapid economic development, lifestyle changes and more aging population in China have led to higher incidence and morbidity of chronic disease in the past 30 years. Chronic kidney disease (CKD) is one of these examples. The statistics show that the incidence in China has reached 10.8 % with notable differences among regions. The incidence in the north (16.9 %) and the southwest (18.3 %) is higher than that of any other regions in China. It is estimated that there are about 119.5 million patients with CKD, but only 12.5 % of them aware of that, of which approximately 2 % (2–3 million) of CKD patients suffer from end-stage renal disease (ESRD) which requires hemodialysis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zhang L, Wang F, Wang L et al. Prevalence of chronic kindeny disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–22.
Liu LS. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39(7):579–615.
Shen J, Goyal A, Sperling L. The emerging epidemic of obesity, diabetes and the metabolic syndrome in China. Cardiol Res Pract. 2012;2012:178675.
Zuo L, Wang M. Current burden and probable increasing incidence of ESRD in China. Clin Nephrol. 2010; 74 (Suppl 1): S20–S22.
Feng Z, Liu C, Guan X, Mor V. China's rapidly aging population creates policy challenges in shaping a viable long-term care system. Health Aff. (Millwood) 2012;31(12):2764–2773.
Liu ZH. Nephrology in China. Nat Rev Nephrol. 2013;9(9):523–528
Zhang X, Wang L, Li J, et al. Etiology analysis of incident hemodialysis patients in Shanxi province during 2010 and 2013. Natl Med J China. 2014;94(22):1714–1717
Chen Y, Lin Y, Ye Ch, et al. Vascular access investigation in a hemodialysis center in Shanghai. China J Blood Purif. 2011;10(10):538–541
Tan J, Qi AR, Han XW, et al. Current situation analysis of maintenance hemodialysis patients in single hemodialysis center in Shenzhen. J Clin Nephrol. 2014;14(10)608–611
Zhou C, Jiang H, Zhang P, et al. The application status of vascular access at initiation of hemodialysis in patients with end stage renal disease-a single center study. Chin J Nephrol. 2014;30(12):897–902.
Zhang L, Qi L, Wang Y, et al. Predictors of incident arteriovenous fistula use in incident hemodialysis patients: A single-center hospital in Beijing. J Clin Nephrol. 2013;13(8):346–349
Wang Y, Ye CH, Jing Q. Chinese expert consensus for hemodialysis vascular access (First Edition) [J]. China J Blood Purif. 2014;13(8):549–558
Qing Yu, Hua Yu, Jiebo Huang, et al. Distribution and complications of native arteriovenous fistulas in maintenance hemodialysis patients: a single-center study. J Nephrol. 2011;24(5):597–603.
Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008;299:2164–2171
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ye, Z., Fan, X. (2017). Hemodialysis Access Management in China. In: Dardik, A. (eds) Vascular Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-33745-6_37
Download citation
DOI: https://doi.org/10.1007/978-3-319-33745-6_37
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33743-2
Online ISBN: 978-3-319-33745-6
eBook Packages: MedicineMedicine (R0)